Systematic review with meta-analysis: Inflammatory bowel disease in the elderly

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 5, 2014, Pages 459-477

  Gisbert, J P ^a   Chaparro, M ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; HUMANS; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED;

EID: 84893767708     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12616     Document Type: Review

References (181)

1. Katz S, Pardi DS,. Inflammatory bowel disease of the elderly: frequently asked questions (FAQs). Am J Gastroenterol 2011; 106: 1889-97.
2. Ha CY, Katz S,. Clinical outcomes and management of inflammatory bowel disease in the older patient. Curr Gastroenterol Rep 2013; 15: 310.
3. Hussain SW, Pardi DS,. Inflammatory bowel disease in the elderly. Drugs Aging 2010; 27: 617-24.
4. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR,. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 2000; 46: 336-43.
5. Lashner BA, Kirsner JB,. Inflammatory bowel disease in older people. Clin Geriatr Med 1991; 7: 287-99.
6. Lindner AE,. Inflammatory bowel disease in the elderly. Clin Geriatr Med 1999; 15: 487-97.
7. Kusugami K, Ina K,. Are the clinical features of ulcerative colitis different in the elderly? J Gastroenterol 2001; 36: 354-5.
8. Sinha SK,. Why the elderly could bankrupt Canada and how demographic imperatives will force the redesign of acute care service delivery. Healthc Pap 2011; 11: 46-51.
9. Charpentier C, Salleron J, Savoye G, et al,. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut 2013 [Epub ahead of print].
10. Russel MG, Stockbrugger RW,. Epidemiology of inflammatory bowel disease: an update. Scand J Gastroenterol 1996; 31: 417-27.
11. Greenwald DA, Brandt LJ,. Inflammatory bowel disease after age 60. Curr Treat Options Gastroenterol 2003; 6: 213-25.
12. Katz S, Feldstein R,. Inflammatory bowel disease of the elderly: a wake-up call. Gastroenterol Hepatol (N Y) 2008; 4: 337-47.
13. Shivananda S, Lennard-Jones J, Logan R, et al,. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690-7.
14. Heresbach D, Alexandre JL, Bretagne JF, et al,. Crohn's disease in the over-60 age group: a population based study. Eur J Gastroenterol Hepatol 2004; 16: 657-64.
15. Ekbom A, Helmick C, Zack M, Adami HO,. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991; 100: 350-8.
16. Swaroop PP,. Inflammatory bowel diseases in the elderly. Clin Geriatr Med 2007; 23: 809-21, vi.
17. del Val JH,. Old-age inflammatory bowel disease onset: a different problem? World J Gastroenterol 2011; 17: 2734-9.
18. Picco MF, Cangemi JR,. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am 2009; 38: 447-62.
19. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR,. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998; 114: 1161-8.
20. Loftus CG, Loftus EV Jr, Harmsen WS, et al,. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007; 13: 254-61.
21. Lakatos PL, David G, Pandur T, et al,. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. J Crohns Colitis 2011; 5: 5-13.
22. Rose JD, Roberts GM, Williams G, Mayberry JF, Rhodes J,. Cardiff Crohn's disease jubilee: the incidence over 50 years. Gut 1988; 29: 346-51.
23. Herrinton LJ, Liu L, Lewis JD, Griffin PM, Allison J,. Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002. Am J Gastroenterol 2008; 103: 1998-2006.
24. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A,. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999; 149: 916-24.
25. Gower-Rousseau C, Vasseur F, Fumery M, et al,. Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis 2013; 45: 89-94.
26. Travis S,. Is IBD different in the elderly? Inflamm Bowel Dis 2008; 14 (Suppl. 2): S12-3.
27. Piront P, Louis E, Latour P, Plomteux O, Belaiche J,. Epidemiology of inflammatory bowel diseases in the elderly in the province of Liege. Gastroenterol Clin Biol 2002; 26: 157-61.
28. Jones HW, Hoare AM,. Does ulcerative colitis behave differently in the elderly? Age Ageing 1988; 17: 410-4.
29. Maeda Y, Morise K, Kanayama K, Saitoh Y,. An elderly case of Crohn's disease complicated with internal fistula and mass formation with a review of the Japanese literature. Nihon Ronen Igakkai Zasshi 1989; 26: 638-43.
30. Zeman R, Burrell M, Gold JA,. Ulcerative colitis in the elderly. AJR Am J Roentgenol 1980; 135: 164-6.
31. Foxworthy DM, Wilson JA,. Crohn's disease in the elderly. Prolonged delay in diagnosis. J Am Geriatr Soc 1985; 33: 492-5.
32. Wagtmans MJ, Verspaget HW, Lamers CB, van Hogezand RA,. Crohn's disease in the elderly: a comparison with young adults. J Clin Gastroenterol 1998; 27: 129-33.
33. Harper PC, McAuliffe TL, Beeken WL,. Crohn's disease in the elderly. A statistical comparison with younger patients matched for sex and duration of disease. Arch Intern Med 1986; 146: 753-5.
34. Zimmerman J, Gavish D, Rachmilewitz D,. Early and late onset ulcerative colitis: distinct clinical features. J Clin Gastroenterol 1985; 7: 492-8.
35. Gabrielli F, Di Gioia F, Di Sibio T, Chiarelli M, Campanelli G, Pietri P,. Crohn's disease in the elderly. Ann Ital Chir 1995; 66: 851-6.
36. Peppercorn MA,. Drug-responsive chronic segmental colitis associated with diverticula: a clinical syndrome in the elderly. Am J Gastroenterol 1992; 87: 609-12.
37. Harpaz N, Sachar DB,. Segmental colitis associated with diverticular disease and other IBD look-alikes. J Clin Gastroenterol 2006; 40 (Suppl. 3): S132-5.
38. Koutroubakis IE, Antoniou P, Tzardi M, Kouroumalis EA,. The spectrum of segmental colitis associated with diverticulosis. Int J Colorectal Dis 2005; 20: 28-32.
39. Hadithi M, Cazemier M, Meijer GA, et al,. Retrospective analysis of old-age colitis in the Dutch inflammatory bowel disease population. World J Gastroenterol 2008; 14: 3183-7.
40. Tchirkow G, Lavery IC, Fazio VW,. Crohn's disease in the elderly. Dis Colon Rectum 1983; 26: 177-81.
41. Montoro MA, Brandt LJ, Santolaria S, et al,. Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study). Scand J Gastroenterol 2011; 46: 236-46.
42. Pardi DS, Loftus EV Jr, Camilleri M,. Treatment of inflammatory bowel disease in the elderly: an update. Drugs Aging 2002; 19: 355-63.
43. Brandt L, Boley S, Goldberg L, Mitsudo S, Berman A,. Colitis in the elderly. A reappraisal. Am J Gastroenterol 1981; 76: 239-45.
44. Akerkar GA, Peppercorn MA,. Inflammatory bowel disease in the elderly. Practical treatment guidelines. Drugs Aging 1997; 10: 199-208.
45. Faucheron JL,. Toxicity of non-steroidal anti-inflammatory drugs in the large bowel. Eur J Gastroenterol Hepatol 1999; 11: 389-92.
46. Ananthakrishnan AN, Binion DG,. Treatment of ulcerative colitis in the elderly. Dig Dis 2009; 27: 327-34.
47. Munch A, Aust D, Bohr J, et al,. Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis 2012; 6: 932-45.
48. Greth J, Torok HP, Koenig A, Folwaczny C,. Comparison of inflammatory bowel disease at younger and older age. Eur J Med Res 2004; 9: 552-4.
49. Triantafillidis JK, Emmanouilidis A, Nicolakis D, Ifantis T, Cheracakis P, Merikas EG,. Crohn's disease in the elderly: clinical features and long-term outcome of 19 Greek patients. Dig Liver Dis 2000; 32: 498-503.
50. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP,. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004; 99: 2393-404.
51. de Ridder L, Weersma RK, Dijkstra G, et al,. Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease. Inflamm Bowel Dis 2007; 13: 1083-92.
52. Polito JM 2nd, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM,. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996; 111: 580-6.
53. Ha CY, Newberry RD, Stone CD, Ciorba MA,. Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease. Clin Gastroenterol Hepatol 2010; 8: 682-7.
54. Quezada SM, Steinberger EK, Cross RK,. Association of age at diagnosis and Crohn's disease phenotype. Age Ageing 2013; 42: 102-6.
55. Hutton I, Ross HB,. Crohn's disease in the elderly. Proc R Soc Med 1975; 68: 329-30.
56. Gillanders I, Danesh B,. Crohn's disease in the elderly. Postgrad Med J 1991; 67: 314.
57. Gupta S, Saverymuttu SH, Keshavarzian A, Hodgson HJ,. Is the pattern of inflammatory bowel disease different in the elderly? Age Ageing 1985; 14: 366-70.
58. Sinclair TS, Brunt PW, Mowat NA,. Nonspecific proctocolitis in northeastern Scotland: a community study. Gastroenterology 1983; 85: 1-11.
59. Softley A, Myren J, Clamp SE, Bouchier IA, Watkinson G, de Dombal FT,. Inflammatory bowel disease in the elderly patient. Scand J Gastroenterol Suppl 1988; 144: 27-30.
60. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N,. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001; 96: 1116-22.
61. Rhodes J, Rose J,. Crohn's disease in the elderly. Br Med J (Clin Res Ed) 1985; 291: 1149-50.
62. Sankaran SK, Veitch PC,. Crohn's disease presenting as toxic megacolon in an elderly man. Aust N Z J Med 1995; 25: 539-40.
63. Walker MA, Pennington CR, Pringle R,. Crohn's disease in the elderly. Br Med J (Clin Res Ed) 1985; 291: 1725-6.
64. Freeman HJ,. Age-dependent phenotypic clinical expression of Crohn's disease. J Clin Gastroenterol 2005; 39: 774-7.
65. Fabricius PJ, Gyde SN, Shouler P, Keighley MR, Alexander-Williams J, Allan RN,. Crohn's disease in the elderly. Gut 1985; 26: 461-5.
66. Walmsley RS, Gillen CD, Allan RN,. Prognosis and management of Crohn's disease in the over-55 age group. Postgrad Med J 1997; 73: 225-9.
67. Roberts PL, Schoetz DJ Jr, Pricolo R, Veidenheimer MC,. Clinical course of Crohn's disease in older patients. A retrospective study. Dis Colon Rectum 1990; 33: 458-62.
68. Riegler G, Tartaglione MT, Carratu R, et al,. Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian Colon-Rectum Study Group). Dig Dis Sci 2000; 45: 462-5.
69. Satsangi J, Silverberg MS, Vermeire S, Colombel JF,. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-53.
70. Tremaine WJ, Timmons LJ, Loftus EV Jr, et al,. Age at onset of inflammatory bowel disease and the risk of surgery for non-neoplastic bowel disease. Aliment Pharmacol Ther 2007; 25: 1435-41.
71. Triantafillidis JK, Emmanouilidis A, Pomonis E, et al,. Ulcerative colitis in the elderly: clinical patterns and outcome in 51 Greek patients. J Gastroenterol 2001; 36: 312-6.
72. Tsujikawa T, Kitoh K, Andoh A, Sasaki M, Koyama S, Fujiyama Y,. Characteristic of elderly patients with ulcerative colitis and therapeutic issue. Nihon Ronen Igakkai Zasshi 2006; 43: 769-72.
73. Matsumoto S, Miyatani H, Yoshida Y,. Ulcerative colitis: comparison between elderly and young adult patients and between elderly patients with late-onset and long-standing disease. Dig Dis Sci 2013; 58: 1306-12.
74. Grimm IS, Friedman LS,. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am 1990; 19: 361-89.
75. Langholz E, Munkholm P, Davidsen M, Nielsen OH, Binder V,. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 1996; 31: 260-6.
76. Vernier-Massouille G, Balde M, Salleron J, et al,. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 2008; 135: 1106-13.
77. Han SW, McColl E, Barton JR, James P, Steen IN, Welfare MR,. Predictors of quality of life in ulcerative colitis: the importance of symptoms and illness representations. Inflamm Bowel Dis 2005; 11: 24-34.
78. Ananthakrishnan AN, McGinley EL, Binion DG,. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis 2009; 15: 182-9.
79. Odes S, Vardi H, Friger M, et al,. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 2006; 131: 719-28.
80. Loftus EV Jr,. A matter of life or death: mortality in Crohn's disease. Inflamm Bowel Dis 2002; 8: 428-9.
81. Wolters FL, Russel MG, Sijbrandij J, et al,. Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut 2006; 55: 510-8.
82. Farrokhyar F, Swarbrick ET, Grace RH, Hellier MD, Gent AE, Irvine EJ,. Low mortality in ulcerative colitis and Crohn's disease in three regional centers in England. Am J Gastroenterol 2001; 96: 501-7.
83. Toruner M, Loftus EV Jr, Harmsen WS, et al,. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008; 134: 929-36.
84. Naganuma M, Kunisaki R, Yoshimura N, Takeuchi Y, Watanabe M,. A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease. J Gastroenterol 2013; 48: 595-600.
85. Nguyen GC, Sam J,. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008; 103: 2272-80.
86. Ananthakrishnan AN, McGinley EL, Binion DG,. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008; 57: 205-10.
87. Navaneethan U, Parasa S, Venkatesh PG, Trikudanathan G, Shen B,. Prevalence and risk factors for colonic perforation during colonoscopy in hospitalized inflammatory bowel disease patients. J Crohns Colitis 2011; 5: 189-95.
88. Hemminki K, Li X, Sundquist J, Sundquist K,. Cancer risks in Crohn disease patients. Ann Oncol 2009; 20: 574-80.
89. Stallmach A, Hagel S, Gharbi A, et al,. Medical and surgical therapy of inflammatory bowel disease in the elderly-prospects and complications. J Crohns Colitis 2011; 5: 177-88.
90. Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD,. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005; 54: 1121-5.
91. Siegel CA, Marden SM, Persing SM, Larson RJ, Sands BE,. Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis. Clin Gastroenterol Hepatol 2009; 7: 874-81.
92. Peyrin-Biroulet L, Khosrotehrani K, Carrat F, et al,. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology 2011; 141: 1621-8. e1-5.
93. Long MD, Martin CF, Pipkin CA, Herfarth HH, Sandler RS, Kappelman MD,. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology 2012; 143: 390-9.e1.
94. Beaugerie L, Brousse N, Bouvier AM, et al,. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009; 374: 1617-25.
95. Baars JE, Kuipers EJ, van Haastert M, Nicolai JJ, Poen AC, van der Woude CJ,. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey. J Gastroenterol 2012; 47: 1308-22.
96. Karvellas CJ, Fedorak RN, Hanson J, Wong CK,. Increased risk of colorectal cancer in ulcerative colitis patients diagnosed after 40 years of age. Can J Gastroenterol 2007; 21: 443-6.
97. Shaukat A, Virnig DJ, Salfiti NI, Howard DH, Sitaraman SV, Liff JM,. Is inflammatory bowel disease an important risk factor among older persons with colorectal cancer in the United States? A population-based case-control study. Dig Dis Sci 2011; 56: 2378-83.
98. Ekbom A, Helmick CG, Zack M, Holmberg L, Adami HO,. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology 1992; 103: 954-60.
99. Jess T, Gamborg M, Munkholm P, Sorensen TI,. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol 2007; 102: 609-17.
100. Jess T, Loftus EV Jr, Harmsen WS, et al,. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 2006; 55: 1248-54.
101. Brandt LJ, Dickstein G,. Inflammatory bowel disease: specific concerns in the elderly. Geriatrics 1989; 44: 107-11.
102. Benchimol EI, Cook SF, Erichsen R, et al,. International variation in medication prescription rates among elderly patients with inflammatory bowel disease. J Crohns Colitis 2013; 7: 878-89.
103. Juneja M, Baidoo L, Schwartz MB, et al,. Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci 2012; 57: 2408-15.
104. Cross RK, Wilson KT, Binion DG,. Polypharmacy and Crohn's disease. Aliment Pharmacol Ther 2005; 21: 1211-6.
105. MacLaughlin EJ, Raehl CL, Treadway AK, Sterling TL, Zoller DP, Bond CA,. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging 2005; 22: 231-55.
106. Kane SV,. Strategies to improve adherence and outcomes in patients with ulcerative colitis. Drugs 2008; 68: 2601-9.
107. Kornbluth A, Sachar DB,. Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997; 92: 204-11.
108. Feagins LA, Spechler SJ,. Biologic agent use varies inversely with age at diagnosis in Crohn's disease. Dig Dis Sci 2010; 55: 3164-70.
109. Duffy LF, Daum F, Fisher SE, et al,. Peripheral neuropathy in Crohn's disease patients treated with metronidazole. Gastroenterology 1985; 88: 681-4.
110. Freeman CD, Klutman NE, Lamp KC,. Metronidazole. A therapeutic review and update. Drugs 1997; 54: 679-708.
111. Shakeri-Nejad K, Stahlmann R,. Drug interactions during therapy with three major groups of antimicrobial agents. Expert Opin Pharmacother 2006; 7: 639-51.
112. Muller AF, Stevens PE, McIntyre AS, Ellison H, Logan RF,. Experience of 5-aminosalicylate nephrotoxicity in the United Kingdom. Aliment Pharmacol Ther 2005; 21: 1217-24.
113. Gisbert JP, Gonzalez-Lama Y, Mate J,. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis 2007; 13: 629-38.
114. Wells PS, Holbrook AM, Crowther NR, Hirsh J,. Interactions of warfarin with drugs and food. Ann Intern Med 1994; 121: 676-83.
115. de Boer NK, Wong DR, Jharap B, et al,. Dose-dependent influence of 5-aminosalicylates on thiopurine metabolism. Am J Gastroenterol 2007; 102: 2747-53.
116. Lewis LD, Benin A, Szumlanski CL, et al,. Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction. Clin Pharmacol Ther 1997; 62: 464-75.
117. Gisbert JP, Gomollon F,. Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review. Am J Gastroenterol 2008; 103: 1783-800.
118. Hande S, Wilson-Rich N, Bousvaros A, et al,. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. Inflamm Bowel Dis 2006; 12: 251-7.
119. Szumlanski CL, Weinshilboum RM,. Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine. Br J Clin Pharmacol 1995; 39: 456-9.
120. Thomas TP,. The complications of systemic corticosteroid therapy in the elderly. A retrospective study. Gerontology 1984; 30: 60-5.
121. Akerkar GA, Peppercorn MA, Hamel MB, Parker RA,. Corticosteroid- associated complications in elderly Crohn's disease patients. Am J Gastroenterol 1997; 92: 461-4.
122. Baty V, Blain H, Saadi L, Jeandel C, Canton P,. Fatal myocardial infarction in an elderly woman with severe ulcerative colitis: what is the role of steroids? Am J Gastroenterol 1998; 93: 2000-1.
123. Tilg H, Moschen AR, Kaser A, Pines A, Dotan I,. Gut, inflammation and osteoporosis: basic and clinical concepts. Gut 2008; 57: 684-94.
124. Lichtenstein GR, Sands BE, Pazianas M,. Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 797-813.
125. Han PD, Burke A, Baldassano RN, Rombeau JL, Lichtenstein GR,. Nutrition and inflammatory bowel disease. Gastroenterol Clin North Am 1999; 28: 423-43, ix.
126. Frey BM, Frey FJ,. Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet 1990; 19: 126-46.
127. Rodriguez-D'Jesus A, Casellas F, Malagelada JR,. Epidemiology of inflammatory bowel disease in the elderly. Gastroenterol Hepatol 2008; 3: 269-73.
128. Chaparro M, Ordas I, Cabre E, et al,. Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients. Inflamm Bowel Dis 2013; 19: 1404-10.
129. Govani SM, Higgins PD,. Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD. J Crohns Colitis 2010; 4: 444-9.
130. Keuzenkamp-Jansen CW, DeAbreu RA, Bokkerink JP, Lambooy MA, Trijbels JM,. Metabolism of intravenously administered high-dose 6-mercaptopurine with and without allopurinol treatment in patients with non-Hodgkin lymphoma. J Pediatr Hematol Oncol 1996; 18: 145-50.
131. Vazquez SR, Rondina MT, Pendleton RC,. Azathioprine-induced warfarin resistance. Ann Pharmacother 2008; 42: 1118-23.
132. Jeppesen U, Rasmussen JM, Brosen K,. Clinically important interaction between azathioprine (Imurel) and phenprocoumon (Marcoumar). Eur J Clin Pharmacol 1997; 52: 503-4.
133. Lewis JD, Schwartz JS, Lichtenstein GR,. Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma. Gastroenterology 2000; 118: 1018-24.
134. Morgacheva O, Furst DE,. Use of MTX in the elderly and in patients with compromised renal function. Clin Exp Rheumatol 2010; 28 (5 Suppl. 61): S85-94.
135. Kornbluth A, Present DH, Lichtiger S, Hanauer S,. Cyclosporin for severe ulcerative colitis: a user's guide. Am J Gastroenterol 1997; 92: 1424-8.
136. Ljung T, Karlen P, Schmidt D, et al,. Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. Gut 2004; 53: 849-53.
137. Seiderer J, Goke B, Ochsenkuhn T,. Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University Hospital. Digestion 2004; 70: 3-9.
138. Chevillotte-Maillard H, Ornetti P, Mistrih R, et al,. Survival and safety of treatment with infliximab in the elderly population. Rheumatology (Oxford) 2005; 44: 695-6.
139. Cottone M, Kohn A, Daperno M, et al,. Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol 2011; 9: 30-5.
140. Desai A, Zator ZA, de Silva P, et al,. Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 309-15.
141. Colombel JF, Loftus EV Jr, Tremaine WJ, et al,. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology 2004; 126: 19-31.
142. Schneeweiss S, Setoguchi S, Weinblatt ME, et al,. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum 2007; 56: 1754-64.
143. Genevay S, Finckh A, Ciurea A, Chamot AM, Kyburz D, Gabay C,. Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2007; 57: 679-85.
144. Marchesoni A, Zaccara E, Gorla R, et al,. TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice. Ann N Y Acad Sci 2009; 1173: 837-46.
145. Filippini M, Bazzani C, Favalli EG, et al,. Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: an observational study. Clin Rev Allergy Immunol 2010; 38: 90-6.
146. Lichtenstein GR, Feagan BG, Cohen RD, et al,. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol 2006; 4: 621-30.
147. Khanna D, McMahon M, Furst DE,. Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from here? Arthritis Rheum 2004; 50: 1040-50.
148. Mocciaro F, Russo G, Di Mitri R, Marino A,. Infliximab-induced thrombocytopenia in an elderly patient with ileocolonic Crohn's disease. Inflamm Bowel Dis 2013; 19: E52-3.
149. Casanova MJ, Chaparro M, Martinez S, Vicuna I, Gisbert JP,. Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease. J Crohns Colitis 2012; 6: 1034-7.
150. Vinod J, Vadada D, Korelitz BI, Sonpal N, Panagopoulos G, Baiocco P,. The effect of antiplatelet therapy in patients with inflammatory bowel disease. J Clin Gastroenterol 2012; 46: 527-9.
151. Eaden JA, Abrams KR, Mayberry JF,. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-35.
152. Blonski W, Lichtenstein GR,. Survival in elderly patients with ulcerative colitis and colorectal cancer. Dig Dis Sci 2012; 57: 1435-8.
153. Bamba T, Nishiyama Y,. Clinical features and management of the elderly patients with ulcerative colitis. Nihon Rinsho 1999; 57: 2598-602.
154. Brackmann S, Andersen SN, Aamodt G, et al,. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Scand J Gastroenterol 2009; 44: 46-55.
155. Wang YR, Cangemi JR, Loftus EV Jr, Picco MF,. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States. Am J Gastroenterol 2013; 108: 444-9.
156. Terheggen G, Lanyi B, Schanz S, et al,. Safety, feasibility, and tolerability of ileocolonoscopy in inflammatory bowel disease. Endoscopy 2008; 40: 656-63.
157. Shaukat A, Salfiti NI, Virnig DJ, et al,. Is ulcerative colitis associated with survival among older persons with colorectal cancer in the US? A population-based case-control study. Dig Dis Sci 2012; 57: 1647-51.
158. Carr N, Schofield PF,. Inflammatory bowel disease in the older patient. Br J Surg 1982; 69: 223-5.
159. Ikeuchi H, Uchino M, Matsuoka H, et al,. Prognosis following emergency surgery for ulcerative colitis in elderly patients. Surg Today 2014; 44: 39-43.
160. Murata Y, Ueoka K, Suzuki T, Yura J, Kato F,. An experiment of acute fulminant severe ulcerative colitis in a 75- year-old male-a case report and a consideration of the surgical treatment of elderly patients with severe ulcerative colitis. Nihon Geka Gakkai Zasshi 1987; 88: 216-21.
161. Page MJ, Poritz LS, Kunselman SJ, Koltun WA,. Factors affecting surgical risk in elderly patients with inflammatory bowel disease. J Gastrointest Surg 2002; 6: 606-13.
162. Carlomagno N, Grifasi C, Dumani X, Lo Conte DL, Renda A,. Clinical management of Crohn's disease in the elderly. Ann Ital Chir 2013; 84: 263-7.
163. Bauer JJ, Gorfine SR, Gelernt IM, Harris MT, Kreel I,. Restorative proctocolectomy in patients older than fifty years. Dis Colon Rectum 1997; 40: 562-5.
164. Almogy G, Sachar DB, Bodian CA, Greenstein AJ,. Surgery for ulcerative colitis in elderly persons: changes in indications for surgery and outcome over time. Arch Surg 2001; 136: 1396-400.
165. Delaney CP, Fazio VW, Remzi FH, et al,. Prospective, age-related analysis of surgical results, functional outcome, and quality of life after ileal pouch-anal anastomosis. Ann Surg 2003; 238: 221-8.
166. Michelassi F, Block GE,. Surgical management of Crohn's disease. Adv Surg 1993; 26: 307-22.
167. Dignass A, Lindsay JO, Sturm A, et al,. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis 2012; 6: 991-1030.
168. Pinto RA, Canedo J, Murad-Regadas S, Regadas SF, Weiss EG, Wexner SD,. Ileal pouch-anal anastomosis in elderly patients: is there a difference in morbidity compared with younger patients? Colorectal Dis 2011; 13: 177-83.
169. Cohen JL, Strong SA, Hyman NH, et al,. Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum 2005; 48: 1997-2009.
170. Chapman JR, Larson DW, Wolff BG, et al,. Ileal pouch-anal anastomosis: does age at the time of surgery affect outcome? Arch Surg 2005; 140: 534-9.
171. Church JM,. Functional outcome and quality of life in an elderly patient with an ileal pouch-anal anastomosis: a 10-year follow up. Aust N Z J Surg 2000; 70: 906-7.
172. Kiran RP, El-Gazzaz G, Remzi FH, et al,. Influence of age at ileoanal pouch creation on long-term changes in functional outcomes. Colorectal Dis 2011; 13: 184-90.
173. Farouk R, Pemberton JH, Wolff BG, Dozois RR, Browning S, Larson D,. Functional outcomes after ileal pouch-anal anastomosis for chronic ulcerative colitis. Ann Surg 2000; 231: 919-26.
174. Vavricka SR, Rogler G,. Treatment of severe ulcerative colitis: differences in elderly patients? Dig Dis 2009; 27: 315-21.
175. Pittman J, Rawl SM, Schmidt CM, et al,. Demographic and clinical factors related to ostomy complications and quality of life in veterans with an ostomy. J Wound Ostomy Continence Nurs 2008; 35: 493-503.
176. Stryker SJ, Pemberton JH, Zinsmeister AR,. Long-term results of ileostomy in older patients. Dis Colon Rectum 1985; 28: 844-6.
177. Fleischer DE, Grimm IS, Friedman LS,. Inflammatory bowel disease in older patients. Med Clin North Am 1994; 78: 1303-19.
178. Condie JD Jr, Leslie KO, Smiley DF,. Surgical treatment for inflammatory bowel disease in the older patient. Surg Gynecol Obstet 1987; 165: 135-42.
179. Gisbert JP, Chaparro M, Esteve M,. Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2011; 33: 619-33.
180. Gisbert JP, Chaparro M,. Vaccination strategies in patients with IBD. Nat Rev Gastroenterol Hepatol 2013; 10: 277-85.
181. Gisbert JP, Villagrasa JR, Rodriguez-Nogueiras A, Chaparro M,. Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease. Am J Gastroenterol 2012; 107: 1460-6.